Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating bronchial asthma of children

A technology of bronchial asthma and composition, which is applied in the field of pharmaceutical composition for treating children with bronchial asthma, and can solve problems such as abuse of antibiotics, loss of early diagnosis and early treatment, and non-consideration of treatment in children with asthma

Inactive Publication Date: 2007-08-01
金昌燮
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, in the diagnosis of children, there is a common problem of repeated abuse of antibiotics in the treatment of children's asthma; in the treatment of children's asthma, many areas still stay at the level of oral bronchodilators, oral glucocorticoids and anti-allergic drugs, even in the 18% of children with asthma in mountainous areas have never considered treatment
Among the treated asthmatic children, antibiotics were mistreated according to bacterial respiratory tract infection, which accounted for a considerable proportion (up to 95% according to reports), and many asthmatic children lost the opportunity of early diagnosis and early treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Take 10g of ephedra, 15g of cassia twig, 5g of asarum, 15g of safflower, 10g of Pinellia chinensis, 10g of tangerine peel, 5g of Chuanbei, 10g of peach kernel, 2 pairs of geckos, one long-tailed and one short-tailed. , 10g of licorice, 0.12g of chlorpheniramine and 10mg of diazepam, add 10g of powdered sugar to adjust the taste, crush, pass through a 100-mesh sieve, and put it in a packaging bag for later use.

Embodiment 2

[0042]Take 10g of ephedra, 15g of cassia twig, 5g of asarum, 15g of safflower, 10g of Pinellia chinensis, 10g of tangerine peel, 5g of Chuanbei, 10g of peach kernel, 2 pairs of geckos, one long-tailed and one short-tailed. , 10g of licorice, 30 tablets of chlorpheniramine and 20 tablets of diazepam, add 10g of powdered sugar to adjust the taste, crush, pass through a 100-mesh sieve, and put it in a packaging bag for later use.

[0043] Chlorpheniramine tablets were purchased from Shanxi Jingdetang Pharmaceutical Co., Ltd., and each tablet contained 4 mg of chlorpheniramine maleate.

[0044] Diazepam tablets were purchased from Xinchang Pharmaceutical Factory of Zhejiang Pharmaceutical Co., Ltd., with packaging specifications of 2.5 mg×100 tablets / bottle, and the drug content in each diazepam tablet was 0.5 mg.

experiment example

[0046] 56 children with bronchial asthma were selected, and the clinical characteristics of the patients were as follows:

[0047] ① Intermittent short-term wheezing, coughing, dyspnea, chest tightness, etc., <2 times a week;

[0048] ②Asymptomatic during the intermission period;

[0049] ③ There may be short-term (half an hour) symptoms (wheezing, coughing, dyspnea) during activities;

[0050] ④ Nocturnal wheezing <2 times a month;

[0051] ⑤ Only chronic allergic cough lasts for more than 1 month;

[0052] ⑥ Maximum expiratory flow rate (PEF) or forced expiratory volume in 1 second (FEV1) > 80% of predicted value, PEF variation rate (PEFR) < 20%.

[0053] Take the powder described in embodiment 1. Children aged 1 to 2 take half a pack each time, children aged 3 to 7 take one pack each time, twice a day for 3 months.

[0054] 10 cases were clinically cured (no asthma attack for more than two years); 21 cases were markedly effective (the number of attacks was reduced by m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal composition for treating children's bronchial asthma, which is prepared from the following raw materials together with pharmaceutically acceptable carrying agents: Chinese ephedra 10g, cassia twig 15g, asarum herb 5g, safflower 15g, pinellia tuber 10g, dried orange peel 10g, tendril-leaved fritillary bulb 5g, peach kernels 10g, gecko 2 pieces, licorice root 10g, chlorpheniramine 0.12g and apozepam 10mg.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a pharmaceutical composition for treating children's bronchial asthma. Background technique [0002] Asthma is the most common respiratory allergic disease in childhood. The incidence rate is affected by many factors, and the data vary from place to place. According to foreign reports, in the Scandinavian countries, the prevalence of childhood asthma is between 0.5% and 2.0%, and between 1.5% and 5.1% in the United Kingdom and the United States. The highest prevalence is in Australia, ranging from 5.4% to 7.4%. According to the survey in some parts of the country, the prevalence rate of childhood asthma in my country is 0.5% to 2.0%. Although asthma can start at any age, most start in children. In the United Kingdom, Australia and the United States, almost all studies have shown that at least 30% of asthma patients begin to suffer from asthma before the age of 10....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8966A61P11/06A61K35/56A61K31/4402A61K31/5513A61K35/583
Inventor 金昌燮
Owner 金昌燮
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com